The 1996 World Health Organization (WHO) recommendations for mild hypertension stressed the need to evaluate target-organ lesions as treatment criteria. The effects of both vascular and heart remodelling on hypertension must to be taken into account, as they adversely influence the prognosis of patients with hypertension. It was previously demonstrated that at least three classes of antihypertensive agents were able to decrease morbidity and mortality in patients with hypertension. Meta-analyses have shown that angiotensinconverting enzyme inhibitors seem to have a marked effect on regression of left ventricular hypertrophy
Introduction
The most recent Joint National Committee VI recommendations of 1997 1 clearly state that the definition of hypertension depends on diastolic and/or systolic blood pressure values. The measurement of blood pressure in the physician's office by using classical methods (mercury manometer using the auscultatory method) remains the standard of reference. This measurement can be complemented in certain cases by remote measurements, such as recording in the patient's home, or by ambulatory monitoring. The Joint National Committee VI notes that while the classification of hypertension is based on blood pressure values, it also depends on the extent of organic lesions and the cause of the hypertension. The rate of disease progression in the lesions varies from one person to another in relation to many factors, most of which are unknown. Furthermore, systolic blood pressure does not always correlate with the severity of the organic lesions. Therefore, systolic blood pressure and organic effects should be evaluated separately. The cardiac and vascular function, and in particular, the presence of hypertrophy or remodelling in these areas, should be studied in patients with hypertension.
For many years investigators have focused separately on cardiac or vascular function, and there are very few simultaneous studies of cardiac status and vessel disease. Obviously, the first hurdle is the justification for such studies. There is an anatomic conCorrespondence: Professor Jean-Michel Mallion, Medecine interne et Cardiologie, CHU de Grenoble, BP 217-38043 Grenoble Cedex 9, France (LVH). However, the relationship between drug-induced LVH regression and reduced morbidity and mortality remains to be confirmed. The effect of antihypertensive agents on vascular hypertrophy, as assessed by intimamedia thickness, and their involvement in reducing morbid events, also have to be determined at the vascular level. As experimental data have highlighted the involvement of angiotensin II in animal models of LVH and vascular hypertrophy development, the role of angiotensin II AT 1 receptor blockers should also be assessed in this indication.
tinuity between the heart and the vessels. This continuity does not, however, imply pathologic similarity. Cardiac muscle, and in particular the left ventricle, is composed of myocytes, or muscle cells. Arteries can be either conductance-compliance vessels, predominantly composed of elastic fibres, or resistance-distribution vessels, predominantly composed of muscle fibres. 2 These facts imply that study of more than one vascular territory is necessary, and that data from various sources must be integrated to find clinically significant correlations.
There is also a haemodynamic continuity between the cardiac and vascular systems. The pressure variations in the blood flow emanating from the heart to the periphery are far from being identified. Thus, while mean blood pressure decreases progressively from the heart to the periphery, the pulse blood pressure increases. Likewise, the pressure waves recorded between the ascending aorta and femoral artery are very different in the adult human. 3 According to O'Rourke et al, 4 the major factors contributing to the change in wave contour are cardiac (pattern and duration of ventricular ejection) and vascular (velocity of wave propagation in large arteries), along with the degree of vasomotor tone and of wave reflection in the peripheral beds. Moreover, different patterns are seen in different arteries, in the same artery at different ages, and in the same artery under different physiologic conditions. 4 All of these factors need to be taken into account to compare structural, cardiac, and vascular modifications.
The different hormonal systems directly or indirectly implicated in the regulation of blood pressure, for example, the renin-angiotensin-aldos-terone system, have very important roles in cardiac and vascular remodelling. Initially, it had been thought that angiotensin II intervened in blood pressure regulation in an autocrine manner only. Recent studies have established that this hormone also has effects on cell proliferation, cardiac and vascular remodelling, and growth factors. The transformation of angiotensin I to angiotensin II is mediated by the angiotensin-converting enzyme, but it is now known that in certain vascular territories, other enzyme systems can intervene with their own specificity. Glycoprotein chymases have a specific affinity for angiotensin I in cardiac tissue. In vascular tissues, chymase-like substances (chymostatin sensitive angiotensin II generating enzymes) are substantially responsible for the formation of angiotensin II, which probably varies according to the vascular territory. 5 For these reasons, the results of similar measurements at cardiac and at different arterial levels should be interpreted with caution.
Indices of interest

Vascular versus cardiac indices
At the cardiac level, the indices measured are well defined, and include intraventricular septal thickness, left ventricular internal diameter, relative wall thickness, and left ventricular mass index. At the vascular level, and particularly at the carotid artery level, the indices of interest are arterial wall thickness, end-diastolic diameter, relative wall thickness, and cross-sectional area. It is possible to compare intraventricular septal thickness with arterial wall thickness, the left ventricular internal diameter with arterial end-diastolic diameter, or the cross-sectional area with mass index, but these comparisons need to be interpreted with great caution.
The introduction and the development of ultrasound imaging in the last 20 years has permitted a qualitative and a quantitative approach to the definition of the above indices. Investigation of the cardiac or vascular systems require different ultrasound probes, as their frequencies and image resolution differ. For instance, vascular data recorded during B mode ultrasonography differs from that recorded using radiofrequency signals (wall track or nius 0.2). 6 These different modes of approach explain why the reproducibility of the measurements are not the same at the cardiac level compared to at the vascular level. Precision in the cardiac measurements is much worse, the differences being 15% to 20% for the measure of the left ventricular mass 7 compared to 3% to 10% 8 for measures of the parietal wall thickness in the common carotid artery. Even the technical feasibility of obtaining the measurements is poorer at the cardiac level compared to at the vascular level.
Reference values
Reference values have evolved with time. For example, the reference values for left ventricular mass were initially Ͻ125 g/m 2 for men and Ͻ110 g/m 2 for women. 9 These values have changed, and in recent large series are Ͻ111 g/m 2 for men and Ͻ106 g/m 2 for women. 10 Note, however, that factors such as race and age are not taken into account.
At the vascular level, and particularly at the carotid artery level, the reference values for indices such as the wall dimensions are still under discussion. These measurements vary according to the technique used and the level at which the measurements are taken (for example, in the common carotid artery, at the bifurcation, or in the internal carotid artery). Therefore, wall dimensions can vary from 0.6 to 1 mm. 11 Measurements should not be taken at a localized thickening in the area of a plaque.
The necessity of integrating the haemodynamic data, such as blood pressure, with morphologic data such as wall dimensions, and more so with the arterial strain or the Peterson elastic modulus, 12 for example, has become increasingly clear.
Left ventricular mass and vascular hypertrophy
The terms vascular and cardiac hypertrophy do not correspond to the same adaptive mechanism. At the vascular level it seems more logical to speak of intima-media thickness than of hypertrophy. If one can justifiably compare the vascular and cardiac systems, then it is logical to proceed by examining the prevalence of their association, relationships, and correlations, and distinguishing between data for compliance and resistance vessels.
Compliance vessels (carotid artery)
Roman et al 13 studied 172 healthy subjects with normal blood pressure and noted a 5.2% prevalence of both left ventricular (LVH) and arterial hypertrophy. In 172 asymptomatic patients with untreated hypertension, they found a 12.2% prevalence of LVH, and a similar level of arterial hypertrophy (11%) ( Figure  1 ). These authors also found that in hypertensive patients, arterial hypertrophy was observed in 24% of the patients with LVH, and in 9% of those without LVH.
Baguet et al 14 studied 48 patients with hypertension that had never been treated, and who were selected on the basis of ambulatory blood pressure measurements with a mean blood pressure of 147/96 mm Hg (systolic/diastolic). They used the criteria of Devereux 9 to define LVH with an index of left ventricular mass у125 g/m 2 for men and у110 g/m 2 in women. Their criterion for vascular hypertrophy was an intima-media thickness у1 mm. 15 They found a 30% prevalence of LVH and an 8% prevalence of thickening of the common carotid artery. In this same population, the prevalence of vascular hypertrophy was greater in patients with LVH (20%) than in patients without LVH (2.9%). Thus, depending on the reference values, the reported prevalence may differ.
The left ventricular geometric pattern is also an element to be considered. According to Roman et al, 16 only patients with concentric hypertrophy demonstrated significant increases in carotid artery size, as shown by diastolic diameter, intima-media thickness, and cross-sectional area. Patients with concentric hypertrophy had significant increases in arterial diameter and cross-sectional area compared to those with concentric remodelling. Cuspidi et al 17 studied 62 patients with hypertension who had never received antihypertensive treatment and who had a normal left ventricular mass (Ͻ125 g/m 2 in men and Ͻ110 g/m 2 in women). They reported that the posterior wall of the common carotid artery at end-diastole was significantly thicker in patients with concentric remodelling as defined by a relative wall thickness of у0.45.
More recently, Baguet et al 14 confirmed the presence of a statistical difference in intima-media thickness for patients who had a normal left ventricular geometry, and those with concentric LVH (mean intima-media thicknesses of 0.70 mm and 0.84 mm, respectively) ( Figure 2 ). Cuspidi et al 17 reported, in addition to the presence of cardiac hypertrophy, a significantly higher prevalence of carotid artery plaque in patients with concentric remodelling (34%) than in patients with normal geometry (19%).
In another study performed 267 subjects with normal blood pressure and 209 patients with untreated hypertension, Roman et al 13 noted that the presence of atherosclerotic plaque within the extracranial carotid arteries increases significantly from the lowest quintile of left ventricular mass index to the highest. They reported that absolute and relative left ventricular and common carotid artery wall thicknesses were greater in the group with carotid artery atherosclerosis, and that the prevalence of plaques was highest in the group with concentric hypertrophy (56%), in reference to normal geometric and concentric remodelling groups, despite similarities between groups in age, serum lipids, and tobacco smoking histories. However, it is too soon to conclude that there is a relationship between remodelling and atherosclerosis in hypertension.
The existence of an association between the presence of LVH and vascular hypertrophy does not necessarily imply a correlation. It is no longer questioned that the frequency of LVH is augmented in hypertension. The left ventricular wall thickness and its mass are strongly related to body surface area, systolic blood pressure, and, to a lesser degree, with age. For reasons probably related to technical difficulties, it is only recently that a relationship has been established between the presence of ventricular hypertrophy and the existence of hypertension. In the Kuopio ischaemic heart study in 120 men, hypertension was not associated with the presence of an increase in intima-media thickness. 18 As a result of a number of studies, [19] [20] [21] it is now established that common carotid artery intimamedia thickness and the cross-sectional area are strongly related to age and blood pressure. These results can be further examined by multivariate analysis. Roman et al 20 studied 43 patients with untreated hypertension and found that the relationship between carotid artery and cardiac wall thicknesses and internal dimension remained significant after consideration of age and blood pressure. Later, in a study of 172 patients with untreated hypertension, they confirmed that the carotid artery crosssectional area is related to left ventricular mass (r = 0.33, P Ͻ 0.0005). 13 Cuspidi et al 16 also found a significant correlation between the left ventricular mass and the common carotid artery intima-media thickness (r = 0.43, P Ͻ 0.01) in a cohort of 62 patients with hypertension. This relationship between carotid artery wall thickening and LVH appears to be independent of age, blood pressure, and serum lipid level.
However, Tices et al, 22 using multivariate analysis in 20 patients in whom hypertension was newly diagnosed and not yet treated, and 81 patients with hypertension that had been treated, found that only age, systolic arterial pressure, and Murgo class were independent predictors of carotid artery intimamedia thickness. Thus, in a univariate analysis, the strongest univariate relations to carotid artery thickness were age, systolic arterial pressure, Murgo class, left ventricular mass, and sex. In addition, Baguet et al 14 found a significant correlation 
Resistance arteries (medium sized conduction artery)
Few studies of the relationship between resistance artery indices and hypertension have been done. Sichè et al 23 studied the radial artery intima-media thickness and the media lumen ratio to describe the radial artery structure in 83 patients with essential hypertension who had never been treated. Twentysix patients had LVH (normal left ventricular mass was defined as a mass Ͻ125 g/m 2 in men and Ͻ101 g/m 2 in women). They found no significant difference for intima-media thickness or diameter in patients with or without LVH, In contrast, they did note an increase in the media lumen ratio, which is an expression of concentric remodelling, in the group with LVH.
Boutouyrie et al 24 analysed vessel wall motion by a pulsed ultrasound echo-tracking system (wall track system) in a study of 86 patients with hypertension, where 31 had not been treated, 31 had stopped treatment, and 24 were receiving antihypertensive treatment. They observed a highly significant correlation between left ventricular mean wall thickness and common carotid artery distensibility and compliance. They also noted that the left ventricular mass index was positively correlated to carotid and diastolic luminal cross sectional areas (r = 0.23, P = 0.02). Sichè et al 23 found a significant correlation between the radial media lumen ratio and the relative wall thickness, but this correlation disappeared when age and systolic blood pressure were taken into account.
Causes of structural changes
One can conclude that in compliance vessels such as the carotid artery, there is an association between the presence of remodelling or LVH, and the presence of corresponding modifications at the vessel wall level. Depending on the reference values used to differentiate the presence or absence of modification or anomaly, the prevalence rate may very substantially. Such conclusions are not available for the radial artery.
It is logical to consider that these structural changes in arteries and in the heart, which occur in hypertension, may be in response to similar factors, but one must not confuse large arteries and resistant arteries. In this context, both haemodynamic and humoral influences should be taken into account. The parallel increase of left ventricular and carotid artery dimensions in patients with hypertension are in part the result of increased blood pressure. It is probable that additional haemodynamic abnormalities may contribute to the observed parallels between cardiac and vascular hypertrophy. Thus, changes in arterial properties such as vascular hypertrophy or atherosclerosis may cause an earlier return of reflected pressure waves to the central circulation. An elevation of effective arterial compliance may thereby stimulate increases in left ventricular mass and relative wall thickness without a detectable alteration in systolic or diastolic arterial pressure. 25, 26 The association between carotid artery atherosclerosis and increasing left ventricular mass may be explained by higher levels of both distending pressure and pulsatile force, resulting in greater susceptibility to endothelial damage. 16, 18 The observations by Boutouyrie et al 24 that left ventricular mean wall thickness and mass volume ratio were inversely related to carotid artery distensibility and compliance are consistent. Nonetheless, one cannot exclude the possibility of other factors (humoral, genetic, etc.) which may be important in determining cardiac and vascular hypertrophy in hypertension.
Clinical implications
Diagnosis
The observation of remodelling and hypertrophy of a vessel wall at a relatively early stage of hypertension, even before cardiac hypertrophy is evident, and when only cardiac remodelling exists, may in itself justify the systematic practice of vascular examinations in patients with hypertension. 16 In the future, the determination of simultaneous alterations, such as hypertrophy in the heart and the vasculature, should allow better estimation of the systemic effects and severity of hypertension. However, these extra investigations would not be justified unless there are prognostic or therapeutic implications.
Prognosis
The prognostic usefulness of studying left ventricular function in hypertension is now well established. Thus, the presence of ventricular hypertrophy, and in particular LVH, is an indisputable risk factor for both acute or chronic coronary artery disease, sudden death, and the development of cardiac failure. The mechanisms implicated include an augmentation of cardiac arrhythmia. The relative roles of atherosclerosis, myocardial fibrosis, alteration of coronary reserve, or other factors to explain these outcomes remain to be established. [27] [28] [29] [30] [31] [32] [33] [34] [35] An association between the presence of LVH and the risk of cerebrovascular accidents has been reported. 36 Likewise, more severe retinopathy and increased proteinuria have been shown in patients with LVH, and in particular, with concentric hypertrophy. 37 Regarding vascular changes, Bonithon-Kopp, in a recent review of the literature, 38 showed that intimamedia thickening is clearly associated with an atherogenic profile, suggesting it may be a marker of early atherosclerosis. This risk is expressed by an increased number of myocardial infarctions, and with rates of coronary insufficiency, cerebrovascular accidents, and peripheral vascular disease. [39] [40] [41] In these studies, hypertension is a relative limited risk factor in the absence of increased intima-media thickness.
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Figure 3
Change in LV mass from baseline values with single-drug therapy at 1 year by pretreatment LV mass tertile. For highest tertile of pretreatment LV mass, significant reductions were seen for hydrochlorothiazide, captopril, and atenolol. For lowest tertile, increases were associated with diltiazem. *P Ͻ 0.05; **PϽ 0.001; ***P Ͻ 0.001 vs baseline. The question arises as to whether the simultaneous presence of LVH and intima-media thickness in the carotid artery is a cumulative risk. To date there is no epidemiologic answer available. For some authors, 17 the association of an increased frequency of carotid artery plaques in the context of concentric LVH, and perhaps the increased frequency of carotid artery plaques in the presence of intima-media thickness, could possibly explain the increased risk of cerebrovascular accidents and concentric LVH. In fact, to consider the presence of carotid artery lesions together with LVH as an increased cumulative risk is premature, and further long-term studies are needed.
Treatment
The expected results of antihypertensive treatment are not only to normalise the blood pressure values, but also to cause regression or disappearance of lesions in the target organs. Regarding LVH, two meta-analyses by Dahlö f et al 42 and by Schmieder et al 43 have shown that not all classes of antihypertensive drugs have a similar effect, and it seems that angiotensin-converting enzyme inhibitors have a greater effect in reducing LVH than do beta-blockers, or diuretics in particular. Neaton et al 44 did not find the same results in their randomised, double-blind, placebo-controlled clinical trial. Studying five antihypertensive drugs (acebutolol, amlodipine, chlorthalidone, doxazosin, and enalapril), they concluded that differences in drug treatments were minimal and not statistically significant.
More recently, Gottdiener et al 45 did a comparison of six antihypertensive agents (hydrochlorothiazide, captopril, atenolol, prazosin, diltiazem, and clonidine). They observed that these antihypertensive drugs have disparate effects on the left ventricular mass, independent of the magnitude of blood pressure reduction. Patients with adequate blood pressure control taking captopril, hydrochlorothiazide, and atenolol, showed reduction of left ventricular mass after 1 year of treatment; patients taking clonidine, diltiazem, or prazosin did not (Figure 3) .
The effect of antihypertensive treatment on remodelling or vascular hypertrophy has not been extensively studied. While one large study of isradipine has been done (MIDAS 46 ), we have to wait for the results of the Verapamil Hypertension Atherosclerosis Study (VHAS) comparing isradipine with chlorthalidone, of the European Lacidipine Study of Atherosclerosis (ELSA) comparing lacidipine with atenolol, and of the Plaque Hypertension Lipid Lowering Study (PHYLLIS) comparing fosinopril with hydrochlorothiazide. The objective of the MIDAS study was to study the effects of isradipine or hydrochlorothiazide on intima-media thickening of carotid arteries. After 3 years of follow-up, there were no differences concerning the intima-media thickness. 46 More studies of this relationship should be done with larger numbers of patients.
While some antihypertensive drugs seem to have an effect on remodelling, the significance of these effects in terms of prognosis is still to be proved in this field. In a study that has been presented but not published, Koren et al 47 followed up 161 patients with hypertension for 10 years, taking into account the left ventricular mass and cardiovascular mortality (myocardial infarction, stroke, heart failure, and cardiac death). They concluded that when there is a decrease in left ventricular mass, there is a decrease in the risk of vascular complications during treatment, and conversely, when there is an increase during treatment of left ventricular mass, there is an increase of cardiovascular complication. In the same fashion, Muiesan et al 48 have studied the morbidity and mortality (myocardial infarction, stroke, heart failure, and cardiac death) of 215 patients with hypertension followed up for 10 years (Table 1) . Their results suggest that lack of regression of LVH is a stronger indicator of cardiovascular risk than a depressed baseline midway left ventricular performance.
So there is much more information to be had before rushing to any conclusions. It does seem, however, that regression of LVH during treatment indicates a good prognosis.
